✦ LIBER ✦

A clinical evaluation of the use of decamethonium bromide (C10) in convulsive shock therapy

✍ Scribed by Matthew Brody

Publisher: Springer US
Year: 1952
Tongue: English
Weight: 447 KB
Volume: 26
Category: Article
ISSN: 0033-2720
DOI: 10.1007/bf01568459

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A clinical evaluation of pyridostigmin b

A clinical evaluation of pyridostigmin bromide in the reversal of curarization

✍ Alexander W. Gotta; Colleen A. Sullivan 📂 Article 📅 1970 🏛 Springer-Verlag 🌐 French ⚖ 490 KB

The role of central venous oximetry, lac

The role of central venous oximetry, lactic acid concentration and shock index in the evaluation of clinical shock: a review

✍ Mohamed Y. Rady 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 483 KB

The use ofLactobacillus rhamnosusin the

The use ofLactobacillus rhamnosusin the therapy of bacterial vaginosis. Evaluation of clinical efficacy in a population of 40 women treated for 24

✍ Alessandro Rossi; Thomas Rossi; Marco Bertini; Giorgio Caccia 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 300 KB

A clinical appraisal of the use of non-d

A clinical appraisal of the use of non-directive therapy in the care of the chronically ill

✍ Morton A. Seidenfeld 📂 Article 📅 1948 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 3 views

The clinical use of P300 event related p

The clinical use of P300 event related potentials for the evaluation of cholinesterase inhibitors treatment in demented patients

✍ E. A. Werber; R. Gandelman-Marton; C. Klein; J. M. Rabey 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 198 KB

Consensus conference on the use of 90-yt

Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian Society of Hematology

✍ Umberto Vitolo; Giovanni Barosi; Stefano Fanti; Alessandro M. Gianni; Maurizio M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

90-yttrium-ibritumomab-tiuxetan is approved for treatment of rituximab-relapsed/refractory CD201 follicular B-cell lymphoma and as consolidation therapy in untreated follicular lymphoma. Recommendations on the use of 90-yttrium-ibritumomab tiuxetan were issued in a consensus conference, sponsored by